MoneyWorks4Me

Auro Laboratories - Quaterly Results

14 Feb 2025 Evaluate
The Sales for the quarter ended December 2024 of Rs. 30.55 million declined by -83.01% from Rs. 179.78 millions.A radical decline of -98.13% was reported in the net profit of the company for the quarter ended December 2024 to Rs. 0.51  millions from Rs. 27.34 millions.The Operating Profit of the company witnessed a decrease to 5.84 millions from 45.03 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 30.55 179.78 -83.01 118.76 281.61 -57.83 536.35 528.94 1.40
Other Income 1.41 4.23 -66.67 6.52 7.88 -17.26 15.04 9.41 59.83
PBIDT 5.84 45.03 -87.03 31.41 60.21 -47.83 121.74 53.34 128.23
Interest 2.46 4.45 -44.72 7.78 7.12 9.27 7.36 8.14 -9.58
PBDT 3.38 40.58 -91.67 23.63 53.09 -55.49 114.38 45.20 153.05
Depreciation 2.70 2.70 0.00 8.10 5.40 50.00 10.92 10.74 1.68
PBT 0.68 37.88 -98.20 15.53 47.69 -67.44 103.46 34.46 200.23
TAX 0.17 10.54 -98.39 3.90 13.27 -70.61 25.54 10.04 154.38
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -1.87 0.03 -6333.33
PAT 0.51 27.34 -98.13 11.63 34.42 -66.21 77.92 24.42 219.08
Equity 62.32 62.32 0.00 62.32 62.32 0.00 62.32 62.32 0.00
PBIDTM(%) 19.12 25.05 -23.68 26.45 21.38 23.70 22.70 10.08 125.08
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..